Ugo De Giorgi

68PUBLICATIONS
286CO-AUTHORS
Cancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Jul 27, 2026
Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

|Jun 22, 2026
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer.

|Feb 19, 2026
Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Milena Urbini, Thomas F Eleveld, Maurizio Polano

|Nov 27, 2025
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.

Irene Marini, Emilio Francesco Giunta, Silvia Nicolini

|Oct 13, 2025
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer.

Nicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas

|Aug 20, 2025
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Andrea Botticelli, Chiara Cremolini, Simone Scagnoli

Pageof 12

Frequent Collaborators

12 joint publications

Vincenza Conteduca

10 joint publications

Sebastiano Buti

10 joint publications

Giuseppe Schepisi

9 joint publications

Giorgia Gurioli